Description
Linastar M 2.5/850 mg is a combination of Linagliptin (a Dipeptidyl Peptidase-4 (DPP-4) inhibitor) and Metformin Hydrochloride (a Biguanide), formulated to help manage Type 2 Diabetes Mellitus. This dual-action therapy works synergistically to regulate blood glucose levels through different mechanisms:
-
Linagliptin works by increasing insulin release in a glucose-dependent manner and reducing glucagon levels, helping to control postprandial (after-meal) blood glucose levels.
-
Metformin decreases hepatic glucose production, enhances peripheral glucose uptake, and improves insulin sensitivity, thus helping to control overall blood sugar levels.
This combination provides an effective solution for patients who are not adequately controlled by diet and exercise alone or who require additional glucose-lowering medication.
.jpeg)
.webp)
 200MG.webp)
Change Language